One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Search from 250 M+ research papersSearch from 250 M+ research papers
Open Accesshttps://doi.org/10.1182/blood-2021-146412
Copy DOI Journal: Blood |  Publication Date: Nov 5, 2021 |
 Citations: 5 |
Affiliation: Centre Hospitalier Universitaire de Caen, Université de Caen Normandie, Maison des Sciences de l’Homme de Dijon, Sorbonne Université, Assistance Publique – Hôpitaux de Paris, Hôpital Saint-Antoine, Centre Hospitalier Universitaire de Grenoble, University Hospital of Montpellier, Centre Hospitalier Universitaire de Rennes, University of Angers, University of Limoges, Hôpital Privé Jean Mermo, Centre Virchow-Villermé, Nantes Université, Centre Hospitalier Régional Universitaire de Brest, Hôpital Saint-Louis, Université Paris Cité, Inserm, Institut National de Recherche en Santé Publique, Institut Bergonié, Centre Hospitalier Universitaire de Toulouse, University Cancer Institute Toulouse Oncopole, Centre Hospitalier de Versailles, Hôpital Civil, Strasbourg, Centre Léon Bérard, Cancer Research Center of Lyon, Institute Paoli-Calmettes, Hôpital Cardiologique du Haut-Lévêque, Institute Cancer De La Loire Lucien Neuwirth, Centre Hospitalier Universitaire de Nancy, Hôpital Paul-BrousseTreatment-Free Remissions in Newly Diagnosed CP CML Patients Treated with the Combination of Nilotinib + Pegylated Interferon Alpha 2a Versus Nilotinib Alone in the National Phase III Petals Trial
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
